Amoun Pharmaceutical Industries Company
Mohamed Maged Ahmed has extensive work experience in the pharmaceutical industry. Mohamed Maged . started their career in 2004 as a Field Sales Manager at Bristol-Myers Squibb, where they worked until 2009. From 2009 to 2010, they were a Branch Sales Manager at Al Baker Pharma, responsible for pharmaceutical distribution in the UAE. Mohamed Maged . then joined Amoun Pharmaceutical Industries Company as a National Sales Manager from 2010 to 2012. After that, they worked at AstraZeneca as a Sales Manager from 2012 to 2014. Currently, they hold the position of Director of Sales and Distribution at Amoun Pharmaceutical Industries Company, a role they have held since November 2015. Additionally, they also served as a Senior National Sales Manager at the same company starting from June 2014.
Mohamed Maged Ahmed began their education in 1986 at Al Sarwat Secondary School in Saudi Arabia. Mohamed Maged . completed their Bachelor's degree in General Studies at this school in 1989. Mohamed Maged . then attended Cairo University from 1989 to 1994, earning a BSc in Veterinary Medicine. In terms of additional certifications, Mohamed obtained the Best Management Approach certification in November 2002, awarded by the General Manager and obtained from the institution of 500 shares of BMS.
This person is not in any offices
Amoun Pharmaceutical Industries Company
Amoun established its third state-of-the-art factory (Amoun Pharmaceutical Co.) - designed by John Brown Co. in Chicago following all FDA requirements – and is today considered to be one of the largest and most modern pharmaceutical factories in the Middle East and Africa. Amoun has five branches in Egypt which between them, cover all major sales territories: Two branches in Cairo to cover, Amoun's the region of Greater Cairo, one branch in Mansoura to serve the Delta region, one branch in Alexandria to serve Alexandria, Behira, Kafr El-Sheikh and Matrouh Governorates, and one branch in Assuit to serve Upper Egypt, starting from Menia to Aswan Governorates. Since its establishment in 1985objective was, and still is, to supply the pharmaceutical market with high quality products. Amoun is considered to be one of the largest companies in the field of producing human and veterinary pharmaceutical products and food supplements; covering most of the pharmaceutical groups, including 144 items, which cover more than 264 products of different pharmaceutical forms and concentrations These pharmaceuticals take the form of capsules, tablets, dry syrups, powders, effervescents, syrups, solutions, drops, creams, suppositories, sprays, as well as sterile products such as ampoules, vials, sterile eye drops and eye ointments. Amoun’s veterinary products include 20 names covering 30 products of different forms and concentrations. Due to its prestigious reputation as a leading pharmaceutical manufacturer in Egypt, Amoun produces a number of products under licence from international pharmaceutical companies such as Merck (Germany), Rowa Wagner (Germany), Leurquin (France), and Guerbet (France) for diagnostic injectables. Our strategic plan aims to achieve the production of 110 million packages of different pharmaceutical forms amounting to approximately L.E. 780 million by 2009, and approximately 300 million packages amounting to (+/-) L.E. 2 billion by 2015.